Skip to main content
B
BMY
(NYSE)
Bristol-Myers Squibb Company
$59.60-- (--)
Loading... - Market loading

Bristol-Myers Squibb Company (BMY) Stock Price & Financial Analysis

Bristol-Myers Squibb Company Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$59.10 - $60.58
52-Week High$62.89
52-Week Low$42.52
Open$60.23
Volume13.49M
Average Volume (3M)13.49M
Market Cap121.52B
Shares Outstanding2.04B
P/E Ratio (TTM)17.84
Price to Sales (P/S)2.61
Price to Book (P/B)6.81
EV/EBITDA10.56
Revenue (TTM)48.20B
Net Income (TTM)7.05B
Free Cash Flow (TTM)12.85B
EPS (TTM)$3.46
Profit Margin14.64%
Operating Margin28.47%
Return on Equity (ROE)38.19%
Debt to Equity2.44
50-Day MA$59.07
200-Day MA$50.78
52-Week Change3.66%
Annual Dividend$3.12
Dividend Yield5.05%
Payout Ratio90.28%
Last Dividend Ex-DateApr 2, 2026

Frequently Asked Questions About Bristol-Myers Squibb Company

What is the current stock price for BMY?

As of the latest trading session, BMY stock trades at $59.60. The 52-week range is $42.52–$62.89, with a day range of $59.10–$60.58.

What is the P/E ratio for BMY?

Bristol-Myers Squibb Company's trailing P/E ratio is 17.8, meaning investors pay $17.8 for every $1 of annual earnings. Bristol-Myers Squibb Company operates in the Healthcare sector.

Does BMY pay dividends?

Yes, Bristol-Myers Squibb Company pays a 5.05% annual dividend yield ($3.12 per share). The payout ratio is 90.3%. The last ex-dividend date was 2026-04-02.

What do analysts recommend for BMY?

Based on 27 analysts, the consensus for BMY is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BMY?

Bristol-Myers Squibb Company's market capitalization is $121.52B, classifying it as a large-cap company. Bristol-Myers Squibb Company operates in the Healthcare sector within the Drug Manufacturers - General industry.